Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Response to Weingarten, "Methemoglobinemia in the Setting of Chronic Transdermal Lidocaine Patch Use," Pain Medicine 2012.
Wieman MS, Bertarelli DC, Brockbals C.
Pain Med. 2013 Apr 11. doi: 10.1111/pme.12119. [Epub ahead of print] No abstract available.
Related citations
Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects.
Harnett MD, Shipley J, MacLean L, Schwiderski U, Sandage BW Jr.
Clin Drug Investig. 2013 Feb;33(2):133-41. doi: 10.1007/s40261-012-0039-8.
The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tablets.
Fiske WD, Jobes J, Xiang Q, Chang SC, Benedek IH.
J Pain. 2012 Jan;13(1):90-9. doi: 10.1016/j.jpain.2011.10.011.
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release.
Benedek IH, Jobes J, Xiang Q, Fiske WD.
Drug Des Devel Ther. 2011;5:455-63. doi: 10.2147/DDDT.S24372. Epub 2011 Nov 23.
Overview: developmental toxicology: new directions.
Shuey D, Kim JH.
Birth Defects Res B Dev Reprod Toxicol. 2011 Oct;92(5):381-3. doi: 10.1002/bdrb.20312. Epub 2011 Jul 18.
Effects of cohort selection on the results of cost-effectiveness analysis of disease-modifying drugs for relapsing-remitting multiple sclerosis.
Becker RV 3rd, Dembek C.
J Manag Care Pharm. 2011 Jun;17(5):377-81.
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
Rubino M, Summers KH, Puenpatom A, Fu C, Ohsfeldt RL, Ben-Joseph RH.
J Manag Care Pharm. 2011 Jun;17(5):367-76.
Economic impact of potential drug-drug interactions in opioid analgesics.
Summers KH, Puenpatom RA, Rajan N, Ben-Joseph R, Ohsfeldt R.
J Med Econ. 2011;14(4):390-6. doi: 10.3111/13696998.2011.583302. Epub 2011 May 17.
Migraine prevalence by age and sex in the United States: a life-span study.
Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB.
Cephalalgia. 2010 Sep;30(9):1065-72. doi: 10.1177/0333102409355601. Epub 2010 Mar 12.
Protein binding-dependent decreases in hERG channel blocker potency assessed by whole-cell voltage clamp in serum.
Margulis M, Sorota S, Chu I, Soares A, Priestley T, Nomeir AA.
J Cardiovasc Pharmacol. 2010 Apr;55(4):368-76. doi: 10.1097/FJC.0b013e3181d2ce39.
Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults.
Silver N, Sandage B, Sabounjian L, Schwiderski U, Shipley J, Harnett M.
J Clin Pharmacol. 2010 Feb;50(2):143-50. doi: 10.1177/0091270009345498. Epub 2009 Nov 30.
Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA, Victor TW.
Postgrad Med. 2009 Nov;121(6):9-20. doi: 10.3810/pgm.2009.11.2073.
Association between migraine, anxiety and depression.
Victor TW, Hu X, Campbell J, White RE, Buse DC, Lipton RB.
Cephalalgia. 2010 May;30(5):567-75. doi: 10.1111/j.1468-2982.2009.01944.x. Epub 2010 Feb 22.
Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice.
Victor TW, Alvarez NA, Gould E.
J Pain. 2009 Oct;10(10):1051-7. doi: 10.1016/j.jpain.2009.03.019.
The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
Gould EM, Jensen MP, Victor TW, Gammaitoni AR, White RE, Galer BS.
Clin J Pain. 2009 Feb;25(2):116-22. doi: 10.1097/AJP.0b013e3181817ac8.
Efficiency of Thai provincial public hospitals during the introduction of universal health coverage using capitation.
Puenpatom RA, Rosenman R.
Health Care Manag Sci. 2008 Dec;11(4):319-38.
The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale.
Victor TW, Jensen MP, Gammaitoni AR, Gould EM, White RE, Galer BS.
Clin J Pain. 2008 Jul-Aug;24(6):550-5. doi: 10.1097/AJP.0b013e31816b1058.
Effects of the opioid analgesic oxymorphone hydrochloride on reproductive function in male and female rats.
Shuey DL, Stump DG, Carliss RD, Gerson RJ.
Birth Defects Res B Dev Reprod Toxicol. 2008 Feb;83(1):12-8.
Oxymorphone hydrochloride, a potent opioid analgesic, is not carcinogenic in rats or mice.
Shuey DL, Woodland C, Tremblay C, Gregson R, Gerson RJ.
Toxicol Sci. 2007 Mar;96(1):162-73. Epub 2006 Nov 30.
Evidence that oxymorphone-induced increases in micronuclei occur secondary to hyperthermia.
Shuey DL, Gudi R, Krsmanovic L, Gerson RJ.
Toxicol Sci. 2007 Feb;95(2):369-75. Epub 2006 Oct 31.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on